Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 1g

N-(4-Bromophenyl)succinimide, 97%, 25g

1-(4-Methoxy-benzenesulfonyl)-piperidine-2-carboxylic acid, 95.0%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 250mg

Tuyau PharMed® BPT, 3,2 mm, 6,4 mm, 7,50 m

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 250mg

4-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]-4-oxobutanoic acid, 1g

(R)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide, 98%, 250mg

4-Bromo-6-(tert-butyl)dibenzo[b,d]furan, 95.0%, 1g

(3-Formylthiophen-2-yl)boronic acid, 95.0%, 5g

1-(Pyridin-2-yl)cyclopropanecarboxylic acid, 95.0%, 250mg

3-(5-Formyl-furan-2-yl)benzoic acid, 95.0%, 250mg

1-PENTANOL, 3-METHYL-5-PHENYL, 98%, 5g